FLT3
Assoc. Prof. Jessica K. Altman | 2017 ASCO Annual Meeting | Molecular response to gilteritinib, a FLT3 inhibitor, in R/R AML, FLT3+
Anne Villeneuve
,
Jun 8, 2017
,
Expert Opinion